RSS

Ian Bolland

The Association of the British Pharmaceutical Industry (ABPI) has said it shares the UK government’s ambition for life sciences in the UK after publishing its position ahead of trade talks with the European Union. Read more

News

trade dept.jpg

Willy Barton / shutterstock.com

The Department for International Trade has published a 15-page document to invite investors to ‘take a closer look’ at the UK life sciences sector. Read more

News

Ian Bolland speaks to Dr Chee Yang Chen, CEO of biotech Carta Biosciences, to discuss how artificial intelligence (AI) can reverse ageing, issues surrounding drug discovery, and the pressure put on healthcare systems because of care for the elderly. Read more

Opinion

Ian Bolland speaks to Dr Steve Gardner from AI-powered drug discovery player PrecisionLife, formerly Row Analytics, to talk about the company’s rebrand, its AI platform and the projects it’s involved in. Read more

News

With the UK general election on the horizon, what are the implications for pharma and life sciences. Read more

Opinion

A research report from Owen Mumford Pharmaceutical Services estimates market opportunities for emerging biosimilar markets. Read more

News

The UK will need to establish its own systems in parallel with that of the European Union for life sciences in the event of a No Deal Brexit, according to a report from the House of Commons Exiting the EU Committee. Read more

News

New regulations have been unveiled by the pharmacy regulator the General Pharmaceutical Council for the purchasing of medicines online. Read more

News

A survey for The Independent Pharmacy suggests that 83% of the population do not know how to check if a medicine they have purchased online is legitimate. Read more

News

The Topol Review has been launched outlining a vision of a digital future for the NHS using the latest technologies across the themes of genomics, digital medicine, and AI and robotics. Read more

News

Assistant editor Ian Bolland explains how a genomics-based personalised risk assessment is aiming to improve screening programmes for breast cancer. Read more

News

Pharmaceutical company Otsuka America and software treatment firm Click Therapeutics have reached a collaboration agreement to develop and commercialise a prescription digital therapeutic treatment for Major Depressive Disorder (MDD). Read more

News